![]() ![]() SUNSHINE BIOPHARMA SIGNS EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF GEORGIA FOR COVID-19 COMPOUNDS InvestorsHub NewsWire - 8:00:00 AM SUNSHINE BIOPHARMA INITIATES COVID-19 TREATMENT MICE STUDY InvestorsHub NewsWire - 8:00:00 AMĬLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating Target InvestorsHub NewsWire - 6:48:48 AM Sunshine Bio launches COVID-19 treatment mice study Seeking Alpha - 8:48:46 AM Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12:34:31 PM Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12:37:45 PM Sunshine gets new patent application notice of allowance for adva-27a in Europe until 2033 Seeking Alpha - 9:19:08 AMĬLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company History InvestorsHub NewsWire - 6:37:33 AM ![]() ![]() Sunshine Biopharma reports Q1 results Seeking Alpha - 8:50:07 AMĪnnual Report (10-k) Edgar (US Regulatory) - 3:24:52 PM Statement of Ownership (sc 13g) Edgar (US Regulatory) - 4:47:38 PM Quarterly Report (10-q) Edgar (US Regulatory) - 12:02:42 PM Proxy Statement - Other Information (preliminary) (pre 14c) Edgar (US Regulatory) - 6:02:36 AM Information Statement - All Other (definitive) (def 14c) Edgar (US Regulatory) - 6:01:19 AM Current Report Filing (8-k) Edgar (US Regulatory) - 12:37:30 PM ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |